1. Home
  2. BCRX vs NMM Comparison

BCRX vs NMM Comparison

Compare BCRX & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

SELL

Current Price

$8.02

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Logo Navios Maritime Partners LP

NMM

Navios Maritime Partners LP

HOLD

Current Price

$91.49

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
NMM
Founded
1986
2007
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
BCRX
NMM
Price
$8.02
$91.49
Analyst Decision
Buy
Strong Buy
Analyst Count
11
4
Target Price
$20.73
★ $103.00
AVG Volume (30 Days)
★ 4.9M
138.1K
Earning Date
11-02-2026
11-17-2026
Dividend Yield
N/A
★ 0.26%
EPS Growth
★ 381.40
N/A
EPS
N/A
★ N/A
Revenue
★ $25,186,000.00
N/A
Revenue This Year
N/A
$9.14
Revenue Next Year
$4.02
$4.62
P/E Ratio
★ N/A
$7.24
Revenue Growth
N/A
★ N/A
52 Week Low
$6.00
$43.02
52 Week High
$11.22
$95.00

Technical Indicators

Market Signals
Indicator
BCRX
NMM
Relative Strength Index (RSI) 35.10 53.92
Support Level $6.35 $87.25
Resistance Level $8.05 $91.96
Average True Range (ATR) 0.30 2.29
MACD -0.02 -0.33
Stochastic Oscillator 14.16 48.39

Price Performance

Historical Comparison
BCRX
NMM

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About NMM Navios Maritime Partners LP

Navios Maritime Partners LP is an international owner and operator of dry cargo and tanker vessels. Its vessels are generally chartered-out under short-term, medium-term and long-term time charters with an average remaining charter duration of approximately 2.1 years to a group of counterparties. Its fleet consisted of dry bulk vessels, containerships and tanker vessels, including two newbuilding capesize vessels, newbuilding containerships and newbuilding tankers. It operates in single segment.

Share on Social Networks: